EUVIMEDEUVIMED entdecken
Crossref

Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma

Sean Schoeman iD, Fernando Escobar iD, Portia Kreiger, Suzanne MacFarland, Peter Mattei, Phassawan Rungsiprakarn, Abhay Srinivasan iD, Michael Acord

Pediatric Blood & Cancer · 2025-04 · 72 (4)

DOI: 10.1002/pbc.31575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 04.02.2025. Verfasst von Sean Schoeman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Hepatoblastoma, Liver Neoplasms, Image-Guided Biopsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Studies on the use of image‐guided percutaneous biopsy for hepatoblastoma (HB), and recommendations put forth by the pediatric hepatic international tumor trial (PHITT), are limited. It is unknown if sufficient tissue can be obtained for trial enrollment as well as molecular profiling, which will likely play a key role in informing future treatment strategies. Methods and Materials Patients with HB who underwent percutaneous biopsy at initial diagnosis in interventional radiology (IR) over a 12‐year period at a single center were included. Patient demographics, pretreatment extent of disease (PRETEXT) stage, tumor size, and procedure details were collected. Pathology reports and tumor genomic analysis, when performed, were assessed for specimen adequacy. Post‐procedure records were assessed for hemoperitoneum.

Results

A total of 33 percutaneous biopsies were performed on 32 patients [17 female; median age 1.3 years (IQR: 0.7–2.5 years); median weight 10.5 kg (IQR: 7.4–12.7 kg)]. Most ( n = 27) had a single liver lesion, and most ( n = 18) were PRETEXT II. A total of 15 were positive for at least one annotation factor. Median longest tumor axis was 9.3 cm (IQR: 5.0–13.5 cm). A total of 16 patients had concurrent non‐targeted liver biopsy, per PHITT recommendations. An 18‐gauge instrument was most commonly used ( n = 24, 73%) with a median of 8 cores (IQR: 6–12) obtained. There were no instances of hemoperitoneum. Tissue was adequate for histologic diagnosis in 97% ( n = 32), with histologic subtyping obtained in 94% (30/32). When available ( n = 29), comparison with the subsequent surgical resection specimen showed subtype concordance in 15 (52%) patients and minor variations secondary to sampling or treatment effect in 14 patients. Molecular profiling was completed on 21/21 specimens (100%), with 19/21 (90%) showing potentially clinically significant variants, most commonly in CTNNB1 (16/21).

Conclusion

In this single‐center study, percutaneous biopsy resulted in no serious adverse events, a high rate of diagnosis, and successful subtyping and molecular characterization of HB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatoblastomaLiver NeoplasmsImage-Guided BiopsyHumansFemaleMaleInfantChild, PreschoolFollow-Up StudiesPrognosisRetrospective Studies

Stichwörter der Autor:innen

hepatoblastomaimage‐guidedinterventional radiologypercutaneous biopsy

Autor:innen und Institutionen

  • Department of Radiology, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA.
  • The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Anatomical Pathology, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA.
  • Department of Oncology, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA.
  • Division of General, Thoracic and Fetal Surgery, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA.

ORCID-Profile: Sean Schoeman, Fernando Escobar, Abhay Srinivasan

Zitieren

APA

Schoeman, S., Escobar, F., Kreiger, P., MacFarland, S., Mattei, P., Rungsiprakarn, P., Srinivasan, A., & Acord, M. (2025). Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma. Pediatric Blood & Cancer, 72(4). https://doi.org/10.1002/pbc.31575

Vancouver

Schoeman S, Escobar F, Kreiger P, MacFarland S, Mattei P, Rungsiprakarn P, et al. Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma. Pediatric Blood & Cancer. 2025;72(4). doi:10.1002/pbc.31575

BibTeX
@article{Schoeman2025,
  author = {Schoeman, Sean and Escobar, Fernando and Kreiger, Portia and MacFarland, Suzanne and Mattei, Peter and Rungsiprakarn, Phassawan and Srinivasan, Abhay and Acord, Michael},
  title = {Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  volume = {72},
  number = {4},
  doi = {10.1002/pbc.31575}
}
Kostenlos starten →